Page 28 - Sharpening the Focus at UHN
P. 28

PURPOSE, VALUES AND PRINCIPLES
                                                                                                                                                 CLINICAL OPTIMIZATION
                        PURPOSE, VALUES AND PRINCIPLES
                                                                                                                                                   CARING SAFELY
                       CLINICAL OPTIMIZATION
                                                                                                                                                   PATIENT EXPERIENCE
                         CARING SAFELY
                                                                                                                                                   TEAM ENGAGEMENT
                        PATIENT EXPERIENCE
                                                                                                                                                   IT TRANSFORMATION
                        Apr/16 May/16 Jun/16 Jul/16  Aug/16 Sept/16 Oct/16 Nov/16 Dec/16 Jan/17 Feb/17 Mar/17                                     Apr/16 May/16 Jun/16 Jul/16  Aug/16 Sept/16 Oct/16 Nov/16 Dec/16 Jan/17 Feb/17 Mar/17
                        TEAM ENGAGEMENT
        Work of UHN scientists among first                                                                                         Student advocates for peer reviewed
                                                                                                                                                   RESEARCH AND INNOVATION
        projects for BlueRock Therapeutics,                                                                                        asthma app
                         IT TRANSFORMATION
        a new stem-cell research company                                                                                                          From logging sleep and exercise,         After coming across a smart phone app that acts as an

                                                                                                                                                  to tracking heart rate and blood         asthma diary for patients and a data-gathering tool for
                                                                                                                                                  MICHENER INTEGRATION
                        In one of the largest investments       “I truly believe that establishing BlueRock                                       pressure, mobile apps have become        researchers, Shirley immediately wanted to know the
                        ever seen in the bio-tech industry,     Therapeutics at this time is both a visionary and a                               fixtures for people looking to monitor   scientific validity of the app in question.
                         RESEARCH AND INNOVATION
                        two multinational firms are investing   bold move that will lead to new therapies for the                                 their health. There is no shortage of    The app claims to help asthma patients track their
                        US$225 million to launch a Toronto-     treatment of cardiovascular disease,” Dr. Keller told              smart phone applications to offer the latest tools and   asthma triggers and identify their symptoms, however
                        based stem-cell therapy company,        the audience, which included Federal Minister of                   techniques that claim to help keep us healthy.          according to Shirley, there was no evidence that
        BlueRock Therapeutics, which will initially focus on    Innovation, Science and Economic Development,                      Now, one student at The Michener Institute of           the app had gone through the rigorous peer-review
        the work of two UHN scientists.                         Navdeep Bains, Ontario Premier Kathleen Wynne,
                        MICHENER INTEGRATION                                                                                       Education at UHN is advocating for standardized,        process required of many other medical resources.
        The work of Dr. Gordon Keller, a world leader in        Ontario Minister of Research, Innovation and Science,              peer-reviewed apps to help those living with asthma     “We have Canadian Consensus Guidelines on how
        stem cell biology and head of the McEwen Centre for     Reza Moridi, and Rob and Cheryl McEwen, whose                      safely manage their health.                             asthma should be managed,” Shirley says. “Any
        Regenerative Medicine, and Dr. Michael Laflamme,        philanthropy established the McEwen Centre, as well                Third-year Respiratory Therapy student Shirley          of the Consensus Guidelines created for asthma
        a cardiac cell therapy pioneer and Senior Scientist at   as officials from Bayer and Versant, and the scientific,          Quach’s research on the subject recently earned her     management are evidence-based and peer-reviewed.”
        Toronto General Hospital Research Institute, will be part   medical and University of Toronto communities.                 the Dr. Renate Krakauer Research Scholarship, and
        of BlueRock’s first efforts to commercialize an approach   “The launching of BlueRock Therapeutics, in my view,            an opportunity to present in May at the Canadian
        to regenerating heart muscle in patients who have had a   is truly transformative and it will go a long way, be a          Society of Respiratory Therapists (CSRT) conference                    Link to full story: click here.
        heart attack or suffer from chronic heart failure.      major step forward, to establishing Toronto as a global            in Halifax.
        The investment, by German drug maker Bayer              leader in regenerative-medicine based therapeutics,”
        AG and United States-based venture-capital firm         added Dr. Keller, who is also a Senior Scientist at
        Versant Ventures, was formally announced  at a news     Princess Margaret Cancer Centre and a Professor at                                                                               Also Making News
        conference in the MaRS Discovery District.              the U of T.
                                                                                  Link to full story: click here.

                                                                       Also Making News                                                                                                                  Prostate cancer researchers



                                                                                                                                                                                                         discover genetic fingerprint


                                                                                                                                                                                                         TWH goes above and
                                                                            Krembil research prompts
                                                                            rethink on established vision                                                                                                beyond in quest for stroke
                                                                            recovery theory                                                                                                              distinction

                                                                                                                                                                                                         Toronto Rehab trio of
                                                                            Hep C transmitted through lung                                                                                               inventors tackles sleep apnea
                                                                            transplant cured in three months


                                                                            McEwen Centre scientists                           Shirley Quach, a third-year Respiratory Therapy student at The Michener Institute
     Federal Minister of Innovation, Science and Economic Development, Navdeep
     Bains, addresses a news conference at MaRS Discovery District announcing the   produce functional heart pace              of Education at UHN, is advocating for a standardized, peer-reviewed apps to help
     creation of BlueRock Therapeutics as (L to R) Ontario Premier Kathleen Wynne,   maker cells                               those living with asthma safely manage their health. (Photo: UHN)
     Dr. Brad Wouters, UHN’s EVP Science & Research, and Dr. Gordon Keller, head of
     the McEwen Centre for Regenerative Medicine, look on. (Photo: UHN)
     28
     28                                                                                        Sharpening the Focus at UHN     Year in Review 2016 – 2017                                                                                       29
   23   24   25   26   27   28   29   30   31   32   33